{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:14:51Z","timestamp":1793682891503,"version":"4.5.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/cad.0b013e32832e14e1","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T03:37:30Z","timestamp":1248320250000},"page":"682-692","source":"Crossref","is-referenced-by-count":19,"title":["Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts"],"prefix":"10.1097","volume":"20","author":[{"given":"Anne","family":"Monks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Kondapaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Vansant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamille Dumong","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Sehested","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/38664","article-title":"Histone acetylation in chromatin structure and transcription","volume":"389","author":"Grunstein","year":"1997","journal-title":"Nature"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1535-6108(03)00165-X","article-title":"Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?","volume":"4","author":"Johnstone","year":"2003","journal-title":"Cancer Cell"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000079503","article-title":"Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells","volume":"66","author":"Chiba","year":"2004","journal-title":"Oncology"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.180316197","article-title":"Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation","volume":"97","author":"Richon","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1073\/pnas.0500369102","article-title":"Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors","volume":"102","author":"Peart","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2174\/1381612053507567","article-title":"A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitors","volume":"11","author":"Mork","year":"2005","journal-title":"Curr Pharm Des"},{"key":"R11-6-20210203","first-page":"937","article-title":"Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity","volume":"1","author":"Blagosklonny","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"R12-6-20210203","first-page":"3429","article-title":"Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells","volume":"26","author":"Lee","year":"2006","journal-title":"Anticancer Res"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"R14-6-20210203","first-page":"721","article-title":"Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101","volume":"2","author":"Plumb","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-06-0111","article-title":"Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies","volume":"5","author":"Qian","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1479-5876-5-49","article-title":"The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo","volume":"5","author":"Buckley","year":"2007","journal-title":"J Transl Med"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1074\/mcp.M600007-MCP200","article-title":"Quantitative proteomic analysis of post-translational modifications of human histones","volume":"5","author":"Beck","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00280-006-0374-7","article-title":"The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo","volume":"60","author":"Tumber","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2141.2007.06772.x","article-title":"The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage","volume":"139","author":"Feng","year":"2007","journal-title":"Br J Haematol"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1078-0432.CCR-07-1786","article-title":"A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors","volume":"14","author":"Steele","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/CBM-2008-4206","article-title":"Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines","volume":"4","author":"Dejligbjerg","year":"2008","journal-title":"Cancer Biomark"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0463.2008.00957.x","article-title":"Monitoring the effect of belinostat in solid tumors by H4 acetylation","volume":"116","author":"Marquard","year":"2008","journal-title":"APMIS"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/gb-2003-4-10-r70","article-title":"Identifying biological themes within lists of genes with EASE","volume":"4","author":"Hosack","year":"2003","journal-title":"Genome Biol"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1091\/mbc.e05-10-0991","article-title":"Ran is required before metaphase for spindle assembly and chromosome alignment and after metaphase for chromosome segregation and spindle midbody organization","volume":"17","author":"Silverman-Gavrila","year":"2006","journal-title":"Mol Biol Cell"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1148980","article-title":"Centromeric Aurora-B activation requires TD-60, microtubules, and substrate priming phosphorylation","volume":"319","author":"Rosasco-Nitcher","year":"2008","journal-title":"Science"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.4161\/cbt.7.9.6415","article-title":"Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer","volume":"7","author":"Zhang","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/13543780902852560","article-title":"Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor","volume":"18","author":"Gimsing","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R31-6-20210203","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1073\/pnas.182372299","article-title":"The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin","volume":"99","author":"Butler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-6-20210203","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/ijc.23243","article-title":"Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer","volume":"122","author":"Qian","year":"2008","journal-title":"Int J Cancer"},{"key":"R33-6-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00109-007-0260-8","article-title":"Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase","volume":"86","author":"Park","year":"2008","journal-title":"J Mol Med"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1677\/ERC-07-0053","article-title":"Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues","volume":"14","author":"Ulisse","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.leukres.2005.09.014","article-title":"Depsipeptide-resistant KU812 cells show reversible P-glycoprotein expression, hyper-acetylated histones, and modulated gene expression profile","volume":"30","author":"Yamada","year":"2006","journal-title":"Leuk Res"},{"key":"R36-6-20210203","first-page":"151","article-title":"Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines","volume":"2","author":"Glaser","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgn010","article-title":"Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor","volume":"29","author":"Cucciolla","year":"2008","journal-title":"Carcinogenesis"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32832e14e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:57:59Z","timestamp":1786039079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200909000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32832e14e1","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}